Non-Liposomal Lipid Nanoparticle Transfection Reagent for mRNA Delivery
Research
Online Inquiry

Non-Liposomal Lipid Nanoparticle Transfection Reagent for mRNA Delivery

Cat.No: ATR-CTR-0018 Datasheet

Quantities:
- +
Product Details Related Products
Product Name Non-Liposomal Lipid Nanoparticle Transfection Reagent for mRNA Delivery
Catalog No. ATR-CTR-0018
Description A non-liposomal lipid nanoparticle formulation specifically engineered for efficient intracellular delivery of messenger RNA. The ionizable lipid component facilitates endosomal escape at acidic pH, enabling high mRNA translation efficiency with minimal cytotoxicity. The nanoparticle system self-assembles with mRNA upon simple mixing, forming uniform particles suitable for both in vitro cell transfection and in vivo applications including vaccine development and protein replacement therapy research.
Intended Use Delivery of messenger RNA into mammalian cells for transient protein expression, vaccine development, and cell reprogramming applications.
Principle / Technology Ionizable lipid nanoparticle self-assembly with mRNA cargo and pH-dependent endosomal escape
Detection Method Fluorescence microscopy or flow cytometry for reporter mRNA; ELISA or Western blot for protein expression quantification
Sample Type HEK293, HeLa, primary fibroblasts, dendritic cells, T cells, and other mammalian cell types
Performance Range / Specifications Transfection efficiency: 70–95% for mRNA encoding GFP in HEK293 cells; particle size: 80–120 nm
Sensitivity / LOD Detectable protein expression from as little as 50 ng mRNA per 10⁵ cells
Specificity Optimized for mRNA; DNA transfection possible but with lower efficiency than dedicated DNA transfection reagents
Reaction Conditions / Protocol Mix mRNA with lipid nanoparticle reagent at 4:1 (v/w) ratio in acidic buffer; incubate 15 min at room temperature for nanoparticle formation; add to cells in complete medium; expression detectable within 2–6 hr
Components / Formulation Ionizable lipid mixture in ethanol, acidic assembly buffer, neutralization buffer, fluorescent control mRNA (eGFP)
Storage Conditions 2–8 °C for lipid reagent; –80 °C for control mRNA
Shelf Life 6 months for lipid reagent at 2–8 °C; 12 months for control mRNA at –80 °C
Package Specifications 50 transfections (24-well plate format, 0.5 µg mRNA per well)
Product Form Liquid lipid mixture in ethanol; lyophilized control mRNA
Quality Control Each lot validated by eGFP mRNA transfection in HEK293 cells; transfection efficiency and viability compared to reference lot
Key Features Ionizable lipid chemistry provides efficient endosomal escape without the cytotoxicity associated with permanently cationic lipids
Purity Endotoxin-free; sterile-filtered; certified nuclease-free
Concentration As specified (typically 1 mg/mL for lipid reagents)
Activity / Unit Definition Transfection efficiency: ≥70% in HEK293 cells with control plasmid at recommended ratio
Molecular Weight Varies by formulation as specified in product documentation
Source / Origin Synthetic cationic lipids and polymers; recombinant viral components where applicable
pH Range / Optimal pH Lipoplex formation optimal at pH 7.0–7.4
Shipping Conditions Cold packs; some formulations require –20 °C; do not freeze lipid emulsions
Expiration Date / Stability 6–12 months at recommended storage temperature
Regulatory / Compliance Research use only; biosafety level 1 for standard transfection; BSL-2 for viral systems
Compatibility Compatible with serum-containing and serum-free culture media; check product-specific compatibility
Recommended Buffer System Serum-free medium or PBS for complex formation; complete medium for post-transfection culture
Application Notes / Precautions Optimize reagent-to-DNA ratio per cell type; avoid antibiotic during transfection; monitor cytotoxicity
Batch-to-Batch Consistency Transfection efficiency within ±15% of reference lot on HEK293 standard

For research use only, not for clinical use.

0
0

There is no product in your cart.